69 related articles for article (PubMed ID: 604101)
1. Antibody response in humans after administration of whole-virion and split vaccine prepared from two different influenza A/swine viruses.
Závadová H; Vonka V; Domorázková E; Syrůcek L; Stárek M; Hrusková J; Plesník V; Janout V; Uvízl M
Dev Biol Stand; 1977 Jun 1-3; 39():231-4. PubMed ID: 604101
[TBL] [Abstract][Full Text] [Related]
2. Antibody formation in laboratory animals after parenteral application of A/swine influenza virus.
Dolezalová B; Závadová H; Stárek M; Vonka V
Dev Biol Stand; 1977 Jun 1-3; 39():405-8. PubMed ID: 604122
[TBL] [Abstract][Full Text] [Related]
3. Neuraminidase antibodies in serum and nasal washings after immunization by means of live and killed whole virion, split virion and subunit (HA and N) influenza vaccines.
Kuwert EK; Höher PG; Werner J; Scheiermann N; Thraenhart O; Müller B; Kleber G
Dev Biol Stand; 1977 Jun 1-3; 39():77-83. PubMed ID: 604137
[TBL] [Abstract][Full Text] [Related]
4. Immunization against human and swine-like influenza A: serological response to two inactivated vaccines of different formulation.
Cuneo-Crovari P; Giacometti G; Gasparini R; Fontana G
Boll Ist Sieroter Milan; 1976; 55(5):371-8. PubMed ID: 1016590
[TBL] [Abstract][Full Text] [Related]
5. A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly.
Lina B; Fletcher MA; Valette M; Saliou P; Aymard M
Biologicals; 2000 Jun; 28(2):95-103. PubMed ID: 10885616
[TBL] [Abstract][Full Text] [Related]
6. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
[TBL] [Abstract][Full Text] [Related]
8. Modulation of humoral immune response to influenza vaccines by BCG.
Zykov MP; Subbotina TI
Acta Virol; 1985 Sep; 29(5):403-9. PubMed ID: 2866694
[TBL] [Abstract][Full Text] [Related]
9. Serological response to an adsorbed killed trivalent influenza vaccine (including A/New Jersey 8/76 antigen).
Sarateanu D; Ehrengut W; Pressler K
Dev Biol Stand; 1977 Jun 1-3; 39():235-8. PubMed ID: 604102
[TBL] [Abstract][Full Text] [Related]
10. Further researches on live influenza virus vaccines.
De Barbieri A; Crovari P; Cuneo-Crovari P; Giacometti G
Dev Biol Stand; 1977 Jun 1-3; 39():73-6. PubMed ID: 604136
[TBL] [Abstract][Full Text] [Related]
11. Sero-epidemiological survey on human and swine influenza A. Situation at the onset of summer 1976.
Cuneo-Crovari P; Gasparini R; Pellegrino C
Boll Ist Sieroter Milan; 1976; 55(5):463-70. PubMed ID: 189788
[TBL] [Abstract][Full Text] [Related]
12. IgM and IgG antibody responses following immunization of children and adults with influenza A/NJ/76 vaccines.
Boyer KM; Cherry JD; Noble GR
Dev Biol Stand; 1977 Jun 1-3; 39():303-8. PubMed ID: 604113
[TBL] [Abstract][Full Text] [Related]
13. Serological responses to whole and split A/New Jersey vaccines in humans and mice following priming infection with influenza A viruses.
Ennis FA; Wise TG; McLaren C; Verbonitz MW
Dev Biol Stand; 1977 Jun 1-3; 39():261-6. PubMed ID: 604108
[TBL] [Abstract][Full Text] [Related]
14. Antibody response to anti-A/New Jersey/76 vaccines.
Hannoun C; Barme M; Sérié C; Beck H; Aquino J; Thibon M
Dev Biol Stand; 1977 Jun 1-3; 39():249-52. PubMed ID: 604105
[TBL] [Abstract][Full Text] [Related]
15. [Comparison between killed subunit influenza vaccines and whole virion preparations: study of reactions and protective efficacy in children and adults].
Profeta ML; Bigatello A; Vacchini V; Bramati L; Ferrante P
Boll Ist Sieroter Milan; 1980 Jan; 58(6):457-74. PubMed ID: 6778485
[TBL] [Abstract][Full Text] [Related]
16. Experience with monovalent and bivalent influenza vaccines in Canada 1976. Clinical evaluation of vaccines from four sources.
Johnson SE; Pearson EW
Dev Biol Stand; 1977 Jun 1-3; 39():267-72. PubMed ID: 342309
[TBL] [Abstract][Full Text] [Related]
17. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
Stumpa A; Tůmová B
Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986
[No Abstract] [Full Text] [Related]
18. Comparison of one- and two-dose regimens of influenza vaccine for elderly men.
Levine M; Beattie BL; McLean DM
CMAJ; 1987 Oct; 137(8):722-6. PubMed ID: 3651943
[TBL] [Abstract][Full Text] [Related]
19. Influenza immunization in children and young adults: clinical reactions and total and IgM antibody responses after immunization with whole-virus or split-product influenza vaccines.
Bernstein DI; Zahradnik JM; DeAngelis CJ; Cherry JD
Am J Dis Child; 1982 Jun; 136(6):513-7. PubMed ID: 7046421
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of the immunogenicity of aqueous versus aluminium phosphate adsorbed split influenza vaccine C.I.
Ioniţă E; Lupulescu E; Alexandrescu V; Maţepiuc M; Constantinescu C; Creţescu L; Velea L
Arch Roum Pathol Exp Microbiol; 1989; 48(3):265-73. PubMed ID: 2519636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
